Stephen Allen Spector MD
Pediatric Infections Associated with Transplant/Immunocompromised States, Pediatric Vaccinology and Vaccine Preventable Diseases, Perinatal Infections
Professor, Pediatrics, UCSD School of Medicine
Join to View Full Profile
330 Lewis StSan Diego, CA 92103
Phone+1 800-926-8273
Fax+1 619-298-2698
Dr. Spector is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Diego) Medical CenterFellowship, Infectious Disease, 1978 - 1981
University of California (San Francisco)Residency, Pediatrics, 1975 - 1978
Tufts University School of MedicineClass of 1975
Certifications & Licensure
CA State Medical License 1976 - 2025
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Infectious Diseases
Awards, Honors, & Recognition
- Honored The Gertrude and Herman Silver Award from the Children’s, 2010
- Fellow (FAAP) American Academy of Pediatrics
Clinical Trials
- Connect to Protect Partnerships for Youth Prevention Interventions: Phase II Start of enrollment: 2003 Sep 01
- Comparison of Three Hepatitis B Vaccination Regimens in HIV-Positive Youth Start of enrollment: 2004 Jan 01
- Safety and Immune Response to Vicriviroc in Combination Regimens in HIV-Infected ART Experienced Children and Adolescents Start of enrollment: 2009 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsThe single-cell opioid responses in the context of HIV (SCORCH) consortium.Seth A Ament, Rianne R Campbell, Mary Kay Lobo, Joseph P Receveur, Kriti Agrawal
Molecular Psychiatry. 2024-12-01 - 1 citationsPrevalence of detectable HIV-DNA and HIV-RNA in cerebrospinal fluid of youth with perinatal HIV and impaired cognition on antiretroviral therapy.Thor A Wagner, Camlin Tierney, Sharon Huang, Sharon Nichols, Kathleen M Malee
AIDS. 2024-08-01 - 2 citationsImpact of Genetic Variants in ABCG2 , NR1I2 , and UGT1A1 on the Pharmacokinetics of Dolutegravir in Children.Stephen A Spector, Sean S Brummel, Audrey Chang, Andrew Wiznia, Theodore D Ruel
Journal of Acquired Immune Deficiency Syndromes. 2024-03-01
Journal Articles
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 VaccineKaren Kotloff, Stephen A Spector, Carlos Fierro, The New England Journal of Medicine
- Human Immunodeficiency Virus Type-1 gp120 and Tat Induce Mitochondrial Fragmentation and Incomplete Mitophagy in Human NeuronsStephen Spector, MD, mBio
Press Mentions
- New Reassessments of How Clinical Trials Can and Should Be ConductedFebruary 3rd, 2023
- San Diego Toddler Enrolled in Pfizer COVID Vaccine TrialNovember 23rd, 2021
- Pfizer Seeks Emergency Use Authorization from FDA for Vaccine in Children 5 to 11 Years OldSeptember 21st, 2021
- Join now to see all
Grant Support
- HIV Centers for Underrepresented Populations in Research Clinical Trials Unit (CURE CTU)UNIVERSITY OF CALIFORNIA, SAN DIEGO2007–2027
- Host Genetic Factors Associated With CNS Disease Of Hiv-Infected ChildrenNational Institute Of Neurological Disorders And Stroke2011–2012
- University Of California, SAN Diego Clinical Trial UnitNational Institute Of Allergy And Infectious Diseases2007–2012
- Clinical Trial: Impaact 1071National Center For Research Resources2010
- Clinical Trial: Antiretroviral Activity Of Raltegravir In HIV-1 Infected ChildreNational Center For Research Resources2010
- Vitamin D Inhibition Of HIV And M. Tuberculosis Coinfection In MacrophagesNational Institute Of Allergy And Infectious Diseases2009–2010
- Healthy Subject Cell CollectionNational Center For Research Resources2009–2010
- Adolescent Master Protocol (AMP) - Impact Of HIV And ART On GrowthNational Center For Research Resources2008–2010
- Clinical Trial: Pactg P1025 Pharmacokinetic Properties Of Antiretroviral DrugsNational Center For Research Resources2009
- CCTG 560a: Viral Population KineticsNational Center For Research Resources2009
- Clinical Trial: Pactg 1020a Novel Protease Inhibitor Bms-232632 In Children WithNational Center For Research Resources2008–2009
- Clinical Trial: Pactg P1025 Pharmacokinetic Properties Of Antiretroviral Drugs DNational Center For Research Resources2008
- Healthy Donor CellsNational Center For Research Resources2006–2008
- VirologyNational Institute Of Allergy And Infectious Diseases2007
- Pactg P1021 Emtricitabine And Efavirenz And Didanosine In HIVNational Center For Research Resources2007
- Pactg P1025 Pharmacokinetic Properties Of Antiretroviral Drugs During PregnancyNational Center For Research Resources2005–2007
- Pactg 1020a Novel Protease Inhibitor Bms-232632 In Children With HIVNational Center For Research Resources2005–2007
- Pactg P1039 Zidovudine/Lamivudine/Abacavir In Perinatal HIVNational Center For Research Resources2006
- Pediatric AIDS Clinical Trials GroupNational Institute Of Allergy And Infectious Diseases1988–2006
- Pactg P1052 Abacavir PK During Chronic Therapy In HIV InfectionNational Center For Research Resources2005
- Pactg P1022 Protease Inhibitor-Including/Sparing For HIV During PregnancyNational Center For Research Resources2005
- Normal Donor Cells For HIV AssaysNational Center For Research Resources2005
- ACTG 382 DMP 266 In Combination Wit Nelfinavir In Children With HIVNational Center For Research Resources2005
- Pediatric ACTG Coordinating And Operations CenterNational Institute Of Allergy And Infectious Diseases2002–2005
- Adolescent Medicine Trials Unit (AMTU)Eunice Kennedy Shriver National Institute Of Child Health &Human Development2002–2005
- Factors In Pediatric AIDS Transmission And PathogenesisNational Institute Of Allergy And Infectious Diseases2001–2005
- Protease Inhibitor Including Sparing For HIV PregnancyNational Center For Research Resources2004
- Pharmacokinetics Of Antiretrovirals During PregnancyNational Center For Research Resources2004
- Pactg P1021 Emtricitabine/Efavirenz/Didanosine In HIVNational Center For Research Resources2004
- Normal Donor CellsNational Center For Research Resources2004
- Actg382--Dmp 266 In Combination W/Nelfinavir In ChildrenNational Center For Research Resources2004
- Core -- Adolescent Medical TrialsNational Center On Minority Health And Health Disparities2002
- Ritonavir Therapy In HIV-1 Infected Infants And ChildrenNational Center For Research Resources2000–2002
- Comparison Of Combinations Of PI, Nrti, And NnrtiNational Center For Research Resources2000–2002
- ZDV &3tc &Nevirapine &Zdv &3tc &Nevirapine &1592u89 In HIV InfectionNational Center For Research Resources1999–2002
- Evaluation Of Ganciclovir For Congenital CytomegalovirusNational Center For Research Resources1999–2002
- Actg382--I592089 With Standard Zidovudine Therapy In NeonatesNational Center For Research Resources1999–2002
- Adolescent Medicine Trial Network For HIV/AIDSEunice Kennedy Shriver National Institute Of Child Health &Human Development2001
- Pediatric AIDS Clinical Trials Group--Coordinate/OperateNational Institute Of Allergy And Infectious Diseases1999–2001
- Core--Clinical Virology And Specimen BankingNational Institute Of Allergy And Infectious Diseases1998–2001
- ACTG 395 Indinavir W/ Stavudine &Lamivudine In Pediatric HIVNational Center For Research Resources1999
- ACTG 358--Oral Indinavir In HIV Pregnant Women &InfantsNational Center For Research Resources1999
- Actg330--1592u89 In Infants And Children With HIV InfectionNational Center For Research Resources1998–1999
- ACTG 250 Nevirapine In HIV-1 Pregnant Women And NeonatesNational Center For Research Resources1997–1999
- Hivig For The Prevention Of Maternal-Fetal HIV TransmissionNational Center For Research Resources1996–1999
- ACTG 300 Zidovudine VS DDI Monotherapy VS Didovudine PLUS DDI In HIV InfectionNational Center For Research Resources1996–1999
- ACTG 226 Oral Ganciclovir In HIV Infected Children With Cytomegalovirus InfectionNational Center For Research Resources1996–1999
- Pediatric Aids--Factors In Transmission And PathologyNational Institute Of Allergy And Infectious Diseases1995–1999
- Actg383--Dmp 266 In Combination With Nelfinavir In ChildrenNational Center For Research Resources1998
- Pediatric AIDS Clinical Trials Group--Coordinate/OperateNational Institute Of Allergy And Infectious Diseases1997–1998
- Actg179 Evaluation Of Ganciclovir For Congenital CytomegalovirusNational Center For Research Resources1997–1998
- Ctg254 Azithromycin &M-Atovaquone &Azithromycin-Bacterial Infection?D?D?D?D?D?National Center For Research Resources1997
- Actg152 Trial Of AZT VS DDI VS Azt/Ddi In HIV Infected ChildrenNational Center For Research Resources1997
- Salvage DDC For Symptomatic HIV Infected Children Failing DDI TherapyNational Center For Research Resources1996–1997
- Core--Primary Isolation And Specimen BankingNational Institute Of Allergy And Infectious Diseases1994–1997
- Actg240 Trial Of ZDV VS D4T In Children With HIV InfectionNational Center For Research Resources1996
- ACTG 245 Antiretroviral Therapy In Children With Advanced HIVNational Center For Research Resources1996
- Pediatric AIDS Clinical ResearchNational Institute Of Allergy And Infectious Diseases1994–1996
- Developmental Virology ResearchNational Institute Of Allergy And Infectious Diseases1994–1996
- Core--Virology LAB SupportNational Institute Of Allergy And Infectious Diseases1994–1996
- AIDS Clinical TrialsNational Institute Of Allergy And Infectious Diseases1994–1995
- Molecular Interaction Of HIV HCMVNational Institute Of Allergy And Infectious Diseases1989–1995
- Adult AIDS Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases1992–1993
- AIDS Clinical Trials GroupNational Institute Of Allergy And Infectious Diseases1989–1991
- AIDS Clinical Trials Group (Conversion From Ateu)National Institute Of Allergy And Infectious Diseases1988
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
